JP2006176431A - Cosmetic - Google Patents
Cosmetic Download PDFInfo
- Publication number
- JP2006176431A JP2006176431A JP2004370667A JP2004370667A JP2006176431A JP 2006176431 A JP2006176431 A JP 2006176431A JP 2004370667 A JP2004370667 A JP 2004370667A JP 2004370667 A JP2004370667 A JP 2004370667A JP 2006176431 A JP2006176431 A JP 2006176431A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- component
- cosmetic according
- effect
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、老化防止・改善効果に優れた化粧料に関し、更に詳しくは、特に、老化防止・改善効果の即効性及び持続性に優れた化粧料に関する。 The present invention relates to a cosmetic excellent in aging prevention / improvement effects, and more particularly to a cosmetic excellent in immediate effect and sustainability of aging prevention / improvement effects.
近年、老化防止(アンチエイジング)の意識の昂揚と相俟って、各種の老化防止・改善用の皮膚外用剤が提案されている。 In recent years, various external preparations for preventing and improving aging have been proposed in combination with raising awareness of anti-aging.
この種の皮膚外用剤として、例えば、ヒドロキシプリン又はそのアシル化誘導体又はその塩と、オリゴペプチドのアシル化誘導体とを含有してなる、しわ、はりの低下といった皮膚の老化症状の予防、改善効果に優れた皮膚外用剤が提案されている(例えば、特許文献1参照)。 As this type of skin external preparation, for example, hydroxypurine or an acylated derivative thereof or a salt thereof, and an acylated derivative of an oligopeptide, preventing and improving skin aging symptoms such as wrinkles and reduction in acupuncture Have been proposed (see, for example, Patent Document 1).
また、クズ属植物の根やその処理物を含有する豊胸促進剤が提案され(例えば、特許文献2参照)、また、プエラリア・ミリフィカの抽出物を老化防止成分として配合した老化防止用皮膚外用剤が提案されている(例えば、特許文献3参照)。
しかしながら、これらの皮膚外用剤は老化防止・改善効果が十分でないばかりでなく、特に、即効性と持続性が不十分で、長期間に亘って使用を継続する必要がある。
例えば、特許文献1では、乳剤、ローション剤、水中油型クリーム剤、油中水型エモリエントクリームをパネラーに1ヵ月使用させ、使用前後の皮膚状態の変化を観察して評価している。
However, these external preparations for skin are not only insufficient in preventing and improving aging, but are particularly insufficient in immediate effect and sustainability, and need to be used for a long period of time.
For example, in Patent Document 1, emulsions, lotions, oil-in-water creams, and water-in-oil emollient creams are used for one month by a panelist, and changes in the skin condition before and after use are observed and evaluated.
また、特許文献2では、塗布剤をラットに6時間毎に1週間塗布し続け、一定期間後、ラットの乳腺細胞を取り出して細胞の増殖を調べている。
更に、特許文献3では、被験クリームをパネラーに毎日朝と夜の2回、12週間に亘って洗顔後に被験クリームを顔面に塗布させた後、シワ改善効果を評価している。
In Patent Document 2, a coating agent is continuously applied to a rat every 6 hours for 1 week, and after a certain period, the rat mammary cells are taken out and examined for cell proliferation.
Furthermore, Patent Document 3 evaluates the wrinkle improving effect after applying the test cream to the face after washing the face twice a day in the morning and night for 12 weeks.
本発明はこのような従来技術の欠点を解消し、顕著な老化防止・改善効果を示すとともに、驚異的な即効性及び持続性を有する老化防止・改善用化粧料を提供することを目的とする。 An object of the present invention is to solve such drawbacks of the prior art, to provide a remarkable anti-aging / improving effect, and to provide an anti-aging / improving cosmetic material that has remarkable immediate effect and durability. .
本発明者らは、上記課題を解決するために鋭意研究の結果、アシル化オリゴペプチドとマメ科クズ属に属する植物とを含有せしめることにより、適用(塗布)後短時間で(1時間程度の後においても)顕著な効果を発揮するとともに、その効果が持続する(例えば、24時間後においても)化粧料を提供できることを見い出し、本発明を完成するに至った。 As a result of diligent research to solve the above problems, the present inventors have included an acylated oligopeptide and a plant belonging to the genus Leguminosae in a short time (approx. 1 hour) after application (application). It has been found that a cosmetic can be provided while exhibiting a remarkable effect (afterwards) and the effect is maintained (for example, even after 24 hours), and has completed the present invention.
即ち、本発明の請求項1は、(A)アシル化オリゴペプチドと(B)マメ科クズ属に属する植物とを含有してなることを特徴とする化粧料を内容とする。 That is, claim 1 of the present invention includes a cosmetic comprising (A) an acylated oligopeptide and (B) a plant belonging to the genus Leguminosae.
本発明の請求項2は、成分(A)がパルミトイルペンタペプチドである請求項1記載の化粧料を内容とする。 The second aspect of the present invention includes the cosmetic according to the first aspect, wherein the component (A) is palmitoyl pentapeptide.
本発明の請求項3は、成分(B)がプエラリア・ミリフィカの根塊の粉末である請求項1又は2記載の化粧料を内容とする。 The third aspect of the present invention includes the cosmetic according to the first or second aspect, wherein the component (B) is a root mass powder of Pueraria mirifica.
本発明の請求項4は、成分(A)のペプチドのアミノ酸配列がリジン−スレオニン−スレオニン−リジン−セリンで表される請求項1〜3のいずれか1項に記載の化粧料を内容とする。 Claim 4 of the present invention contains the cosmetic according to any one of claims 1 to 3, wherein the amino acid sequence of the peptide of component (A) is represented by lysine-threonine-threonine-lysine-serine. .
本発明の請求項5は、成分(B)の粒子径が150μm以下である請求項1〜4のいずれか1項に記載の化粧料を内容とする。 A fifth aspect of the present invention includes the cosmetic according to any one of the first to fourth aspects, wherein the particle size of the component (B) is 150 μm or less.
本発明の請求項6は、成分(A)の含有量が0.000001〜0.003重量%である請求項1〜5のいずれか1項に記載の化粧料を内容とする。 A sixth aspect of the present invention includes the cosmetic according to any one of the first to fifth aspects, wherein the content of the component (A) is 0.000001 to 0.003% by weight.
本発明の請求項7は、成分(B)の含有量が0.01〜20重量%である請求項1〜6のいずれか1項に記載の化粧料を内容とする。 The seventh aspect of the present invention includes the cosmetic according to any one of the first to sixth aspects, wherein the content of the component (B) is 0.01 to 20% by weight.
本発明の請求項8は、顔のしわやたるみを減少させ、はりをもたせリフトアップするために用いる請求項1〜7のいずれか1項に記載の化粧料を内容とする。 The eighth aspect of the present invention includes the cosmetic according to any one of the first to seventh aspects, which is used for reducing wrinkles and sagging of the face, and for lifting and lifting the beam.
本発明の請求項9は、バストにはりをもたせ、バストアップするために用いる請求項1〜7のいずれか1項に記載の化粧料を内容とする。 A ninth aspect of the present invention includes the cosmetic according to any one of the first to seventh aspects, which is used for giving a bust to the bust and for bust-up.
本発明の請求項10は、ヒップにはりをもたせ、ヒップアップするために用いる請求項1〜7のいずれか1項に記載の化粧料を内容とする。 A tenth aspect of the present invention includes the cosmetic according to any one of the first to seventh aspects, which is used for giving a hip to a hip and raising the hip.
本発明の化粧料は、アシル化オリゴペプチドとマメ科クズ属に属する植物とを含有することにより、アシル化オリゴペプチド単独又はマメ科クズ属に属する植物単体の場合に比べて、驚異的な即効性と持続性を発揮する。 The cosmetic composition of the present invention contains an acylated oligopeptide and a plant belonging to the genus Leguminosae, so that it has a surprising immediate effect as compared with the case of the acylated oligopeptide alone or the plant alone belonging to the genus Legumes. Exhibits sex and sustainability.
従って、従来の化粧料では即効性と持続性が十分でないため、長期間に亘って使用を継続する必要があり、短期間では効果が確認できないために途中で使用を中断したり、挫折するといったケースが多かったが、本発明の化粧料は使用後1時間でも顕著な効果が見られるため、このような使用の中断や挫折といったことがない。 Therefore, since the immediate effect and sustainability of conventional cosmetics are not sufficient, it is necessary to continue the use for a long period of time, and since the effect cannot be confirmed in a short period of time, the use is interrupted or frustrated. There were many cases, but the cosmetics of the present invention show a remarkable effect even 1 hour after use, so there is no such interruption or frustration.
本発明の化粧料の特徴は、(A)アシル化オリゴペプチドと(B)マメ科クズ属に属する植物とを含有せしめたことにある。 The cosmetic of the present invention is characterized in that it contains (A) an acylated oligopeptide and (B) a plant belonging to the genus Leguminosae.
本発明に用いられる(A)アシル化オリゴペプチドとしては、リジン、スレオニン、セリン、グリシン、ヒスチジン等から選択される少なくとも1種のアミノ酸が2〜6個結合したオリゴペプチドのアシル化誘導体が好ましく、就中、パルミトイルペンタペプチドが好ましく、特に、パルミトイル−リジン−スレオニン−スレオニン−リジン−セリンが好ましい。 The acylated oligopeptide (A) used in the present invention is preferably an acylated derivative of an oligopeptide in which 2 to 6 amino acids selected from lysine, threonine, serine, glycine, histidine and the like are bound, Among them, palmitoyl pentapeptide is preferable, and palmitoyl-lysine-threonine-threonine-lysine-serine is particularly preferable.
(A)アシル化オリゴペプチドの含有量は0.000001〜0.003重量%が好ましく、より好ましくは0.00001〜0.0005重量%である。この含有量が0.000001重量%未満では成分(A)を併用する効果が得られず、例えば、しわ、たるみ、きめ、はりの十分な改善効果が得られない傾向がある。一方、0.003重量%を越えても効果はあまり変わらず、却って不経済である。 (A) The content of the acylated oligopeptide is preferably 0.000001 to 0.003% by weight, more preferably 0.00001 to 0.0005% by weight. If the content is less than 0.000001% by weight, the effect of using the component (A) together cannot be obtained, and for example, there is a tendency that a sufficient improvement effect of wrinkles, sagging, texture, and beam cannot be obtained. On the other hand, even if it exceeds 0.003% by weight, the effect does not change so much and it is uneconomical.
本発明に用いられる(B)マメ科クズ属に属する植物としては、プエラリア・ミリフィカが好ましく、根塊、茎、葉を乾燥した後、粉砕して得られる粉末や、これらを水、温水、アルコール等の溶媒で抽出したもの、等が好適に用いられる。特に、根塊の粉末が好ましい。粉末の粒子径は小さい程好ましく、例えば、150μm以下であることが好ましい。粒子径が150μmを越えると、例えば、皮膚に塗布した際にザラツキ感が出るので好ましくない。 (B) The plant belonging to the genus Leguminosae used in the present invention is preferably Pueraria mirifica, a powder obtained by drying the root mass, stem, and leaves and then pulverizing them, water, hot water, alcohol Those extracted with a solvent such as are preferably used. In particular, root mass powder is preferred. The smaller the particle diameter of the powder, the more preferable, for example, 150 μm or less is preferable. When the particle diameter exceeds 150 μm, for example, a rough feeling is produced when applied to the skin, which is not preferable.
(B)マメ科クズ属に属する植物の含有量は、固形分で0.01〜20重量%が好ましく、より好ましくは0.10〜5重量%である。この含有量が0.01重量%未満では成分(B)を併用する効果が得られず、例えば、しわ、たるみ、きめの十分な改善効果が得られず、特に、ふっくらとさせてバストやヒップをアップさせる効果が得られない傾向がある。一方、20重量%を越えても効果はあまり変わらず、却って不経済となり、また粉末を用いる場合にゴテゴテした状態となり製剤化し難い傾向がある。 (B) Content of the plant which belongs to the leguminous genus Kudu is 0.01 to 20 weight% in solid content, More preferably, it is 0.10 to 5 weight%. If the content is less than 0.01% by weight, the effect of using the component (B) in combination cannot be obtained. For example, a sufficient improvement effect of wrinkles, sagging and texture cannot be obtained. There is a tendency that the effect of improving is not obtained. On the other hand, if the amount exceeds 20% by weight, the effect does not change so much, but it is uneconomical.
本発明の化粧料は、上記成分(A)、(B)の他に、必要に応じ、グリチルレチン酸ステアリル等の抗炎症剤、ビタミンB群等の皮脂分泌抑制剤、アラントイン等の細胞賦活剤、ビタミンE等の抗酸化剤、グリセリン、ソルビトール等の保湿剤、酸化チタン、ベンゾフェノン等の紫外線防止剤、アスコルビン酸等の美白剤、パラベン等の防菌防黴剤、その他、安定剤、顔料、香料等各種の添加剤を含有させることができる。 In addition to the above components (A) and (B), the cosmetic of the present invention, if necessary, an anti-inflammatory agent such as stearyl glycyrrhetinate, a sebum secretion inhibitor such as vitamin B group, a cell activator such as allantoin, Antioxidants such as vitamin E, humectants such as glycerin and sorbitol, UV inhibitors such as titanium oxide and benzophenone, whitening agents such as ascorbic acid, antifungal agents such as parabens, other stabilizers, pigments, and fragrances And various other additives can be contained.
本発明の化粧料の型状は、ローション、乳液、ゲル、クリーム、ペースト等のいずれでもよいが、特にクリームが好適である。 The shape of the cosmetic of the present invention may be any of lotion, milky lotion, gel, cream, paste and the like, but cream is particularly preferable.
本発明の化粧料は、例えば、顔に適応した場合には、むくみ、しわを減少させ、きめを改善し、はりをもたせてリフトアップし、またバストに適用した場合には、たるみを減少させ、きめを改善し、はりをもたせてふっくら感を与えてバストアップし、更に、ヒップに適用した場合には、たるみを減少させ、きめを改善し、はりをもたせてふっくら感を与えてヒップアップする効果が顕著で、しかも、驚くべきことに、これらの老化防止・改善効果が従来の同種化粧料では予測もし得なかった際立った即効性と持続性を有することである。
例えば、適用(塗布)後1時間で顕著な改善効果が実感できるとともに、その効果が持続(例えば、24時間後においても殆ど低下しない)する。
The cosmetic of the present invention, for example, reduces swelling and wrinkles when applied to the face, improves texture, lifts with a beam, and reduces sagging when applied to a bust. Improve the texture, give the beam a plump feeling and bust up, and when applied to the hips, reduce sagging, improve the texture, give the beam a plump feeling and hip up The effect of preventing aging is surprising, and surprisingly, these anti-aging / improving effects have outstanding immediate effects and sustainability that could not be predicted by conventional cosmetics of the same kind.
For example, a remarkable improvement effect can be realized in 1 hour after application (application), and the effect is sustained (for example, hardly decreases even after 24 hours).
以下、本発明を実施例及び比較例を挙げて本発明を更に詳細に説明するが、これらは何ら制限するものではない。 EXAMPLES Hereinafter, although an Example and a comparative example are given and this invention is demonstrated further in detail, this does not limit at all.
実施例1、比較例1〜2
表1に示した成分及び配合により、クリームを作成した。成分(A)としては、パルミトイルペンタペプチド(商品名MATRIXYL、クローダジャパン株式会社製)を用い、成分(B)としては、プエラリア・ミリフィカの根塊の粉末(タイ産、輸入元:清光薬品工業株式会社)を電動式ミルで粉砕した後、100メッシュ(150μm)の篩を通過したものを用いた。尚、(B)プエラリア・ミリフィカの根塊粉末は油相成分に、(A)パルミトイルペンタペプチドは水相成分に添加して均一に混合乳化した。
Example 1, Comparative Examples 1-2
A cream was prepared with the ingredients and formulations shown in Table 1. As the component (A), palmitoyl pentapeptide (trade name MATRIXYL, manufactured by Croda Japan Co., Ltd.) is used, and as the component (B), the root mass powder of Pueraria Mirifica (Thailand, importer: Seiko Pharmaceutical Co., Ltd.) Company) was pulverized with an electric mill and then passed through a 100 mesh (150 μm) sieve. The root mass powder of (B) Pueraria mirifica was added to the oil phase component, and (A) palmitoyl pentapeptide was added to the aqueous phase component and uniformly mixed and emulsified.
上記実施例1及び比較例1〜2で得られたクリームの効果を下記の方法により評価した。
即ち、25才〜60才の女性パネラー30名に朝洗顔後に上記クリームをフェイス(顔)、バスト、ヒップにそれぞれ適量塗布してもらい、1時間後及び24時間後に、クリーム塗布による改善効果を下記の基準により評価した。結果を表2に示す。
The effects of the creams obtained in Example 1 and Comparative Examples 1 and 2 were evaluated by the following methods.
That is, 30 female panelists aged 25 to 60 years old apply the appropriate amount of the above cream to their face (face), bust, and hips after washing in the morning. It was evaluated according to the criteria. The results are shown in Table 2.
〔評価方法〕
フェイス(顔)については、「しわ、たるみ、きめ、はり、ふっくら」について、また、バスト及びヒップについては、「たるみ、きめ、はり、ふっくら、アップ」について下記の基準により5段階評価した。
〔Evaluation methods〕
For the face (face), “wrinkle, sagging, texture, beam, plump”, and for the bust and hip, “sag, texture, beam, plump, up” were evaluated according to the following criteria.
5:改善効果が極めて顕著である。
4:改善効果が顕著である。
3:改善効果が普通である。
2:改善効果が余り認められない。
1:改善効果が認められない。
5: The improvement effect is extremely remarkable.
4: The improvement effect is remarkable.
3: The improvement effect is normal.
2: Not much improvement effect is observed.
1: The improvement effect is not recognized.
上記表2の結果から明かなように、本発明の化粧料は、フェイス、バスト、ヒップのいずれの部位においても老化防止・改善効果が顕著であり、しかも適用(塗布)後1時間後に顕著な効果が現れており、またその効果は24時間後においても持続している。
本発明の化粧料は、テスト終了後においてもサンプルを求めるリピーター率は100%で、このような高いリピーター率からもその効果の大きさがわかる。
As is clear from the results in Table 2 above, the cosmetic composition of the present invention has a remarkable anti-aging / improvement effect in any part of the face, bust, and hip, and is prominent one hour after application (application). An effect has appeared and the effect persists after 24 hours.
The cosmetic of the present invention has a repeat rate of 100% for obtaining a sample even after the test is completed, and the magnitude of the effect can be seen from such a high repeater rate.
叙上のとおり、本発明の化粧料は、しわ、たるみを減少させ、きめを改善し、はりやふっくら感を与え、例えば、顔、バスト、ヒップに適用した場合には、それぞれリフトアップ、バストアップ、ヒップアップさせる老化防止・改善効果が顕著である。しかも、これらの老化防止効果は驚異的な即効性を有するので、途中で中止したり挫折したりすることなく、効果を実感しながら使用を継続することができるとともに、効果の持続性にも優れている。
As described above, the cosmetic of the present invention reduces wrinkles and sagging, improves texture, gives a feeling of elasticity and plumpness, for example, when applied to the face, bust, and hips, lift-up and bust, respectively. The anti-aging / improvement effect of raising and hip-up is remarkable. In addition, these anti-aging effects have tremendous immediate effects, so you can continue using them while feeling the effects without stopping or frustrating on the way, and they are also excellent in sustainability. ing.
Claims (10)
The cosmetic according to any one of claims 1 to 7, wherein the cosmetic is used for giving a hip to the hip and raising the hip.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004370667A JP2006176431A (en) | 2004-12-22 | 2004-12-22 | Cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004370667A JP2006176431A (en) | 2004-12-22 | 2004-12-22 | Cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2006176431A true JP2006176431A (en) | 2006-07-06 |
Family
ID=36730883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004370667A Pending JP2006176431A (en) | 2004-12-22 | 2004-12-22 | Cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2006176431A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010528090A (en) * | 2007-05-29 | 2010-08-19 | シャネル パフュームズ ビューテ | Cosmetic composition comprising an active agent capable of stimulating tensin 1 expression |
JP2010241762A (en) * | 2009-04-09 | 2010-10-28 | Korin Pharma Co Ltd | Cosmetic |
JP2015164937A (en) * | 2008-05-29 | 2015-09-17 | セラピューティック・ペプタイズ・インコーポレーテッドTherapeutic Peptides,Inc. | Oligomeric biosurfactants in dermatocosmetic compositions |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0624937A (en) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | Mucopolysaccharide fragmentation-inhibiting agent, active oxygen-scavenging agent, antioxidative agent and cosmetic |
JP2001181170A (en) * | 1999-12-24 | 2001-07-03 | Kose Corp | Skin care preparation |
JP2001220340A (en) * | 2000-02-07 | 2001-08-14 | Kose Corp | Skin preparation for external use for preventing aging |
JP2002524487A (en) * | 1998-09-15 | 2002-08-06 | セデルマ エス.アー. | Use of a peptide for scarring, moisturizing and improving skin appearance as a cosmetic or dermatological agent during natural aging or hyperaging (sun dermatitis, contamination) |
JP2002542178A (en) * | 1999-04-19 | 2002-12-10 | ザ、プロクター、エンド、ギャンブル、カンパニー | Skin care compositions containing combinations of skin care actives |
JP2003508041A (en) * | 1999-08-27 | 2003-03-04 | チェイル ジェダン コーポレーション | Extract derived from Pueraria mirifica, Butea Superba and / or Mukna Koretch and extraction method thereof |
-
2004
- 2004-12-22 JP JP2004370667A patent/JP2006176431A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0624937A (en) * | 1992-06-29 | 1994-02-01 | Narisu Keshohin:Kk | Mucopolysaccharide fragmentation-inhibiting agent, active oxygen-scavenging agent, antioxidative agent and cosmetic |
JP2002524487A (en) * | 1998-09-15 | 2002-08-06 | セデルマ エス.アー. | Use of a peptide for scarring, moisturizing and improving skin appearance as a cosmetic or dermatological agent during natural aging or hyperaging (sun dermatitis, contamination) |
JP2002542178A (en) * | 1999-04-19 | 2002-12-10 | ザ、プロクター、エンド、ギャンブル、カンパニー | Skin care compositions containing combinations of skin care actives |
JP2003508041A (en) * | 1999-08-27 | 2003-03-04 | チェイル ジェダン コーポレーション | Extract derived from Pueraria mirifica, Butea Superba and / or Mukna Koretch and extraction method thereof |
JP2001181170A (en) * | 1999-12-24 | 2001-07-03 | Kose Corp | Skin care preparation |
JP2001220340A (en) * | 2000-02-07 | 2001-08-14 | Kose Corp | Skin preparation for external use for preventing aging |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010528090A (en) * | 2007-05-29 | 2010-08-19 | シャネル パフュームズ ビューテ | Cosmetic composition comprising an active agent capable of stimulating tensin 1 expression |
JP2015164937A (en) * | 2008-05-29 | 2015-09-17 | セラピューティック・ペプタイズ・インコーポレーテッドTherapeutic Peptides,Inc. | Oligomeric biosurfactants in dermatocosmetic compositions |
JP2010241762A (en) * | 2009-04-09 | 2010-10-28 | Korin Pharma Co Ltd | Cosmetic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018525397A (en) | Composition containing extract of wisteria tea and nemunoki and method of using the same | |
JP2001213754A (en) | Cosmetic | |
WO2012157734A1 (en) | Wrinkle-improving composition containing placenta-derived component | |
JPS6220165B2 (en) | ||
JP5765744B2 (en) | Preventive or therapeutic agent for atopic dermatitis, and external preparation | |
JP6351814B1 (en) | Topical skin preparation | |
JP4460420B2 (en) | Collagen production promoter | |
JP2010184916A (en) | Hair growth promoter | |
JP2006176431A (en) | Cosmetic | |
JP5184813B2 (en) | Collagen production promotion and degradation inhibitor | |
US8809279B2 (en) | Peptides that are modulators of the protein TRF2 and compositions containing same | |
KR101689877B1 (en) | Cosmetic composition for treating atopic dermatitis | |
KR101689875B1 (en) | Cosmetic composition for treating atopic dermatitis containing mixtures of peptide and amino acid | |
JPH07145033A (en) | Cosmetic for prevention of dermal aging | |
JP2011231055A (en) | Cosmetic for skin | |
JP2006001837A (en) | Opioid receptor damage inhibitor | |
JP2017019754A (en) | Elastase inhibitor | |
KR100713557B1 (en) | Cosmetic composition for skin whitening comprising ramulus mori extract and hexanoyl-tripeptide as active ingredient | |
JP2007106733A (en) | Extract of momordica grosvenori swingla and skin care composition for external use containing sophorolipid | |
JP2774071B2 (en) | Hair restoration cosmetics | |
JP6322368B2 (en) | Hair cosmetic and skin cosmetic containing PGD2 production inhibitor and 5α-reductase activity inhibitor | |
JPH04334308A (en) | Skin cosmetic | |
JP2001114664A (en) | Cosmetic | |
JP2006131557A (en) | Skin care preparation for external use | |
JP2001002527A (en) | Composition for skin preparation for external use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071221 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100402 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100713 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100910 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101109 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110830 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120131 |